Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 6Recruiting 5Unknown 3Terminated 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Genitourinary 3Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasms 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Lung Neoplasms 1Hemangioma 1Disease 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Urine Specimen Collection × Clear all
NCT02807129 2026-01-21

AgElOn

CHU de Reims

Phase NA Completed
296 enrolled
Tumor-Agnostic

Neoplasms

NCT02657863 2025-12-23

Cancer DNA Detection in Blood and Urine

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Completed
61 enrolled
Genitourinary

Prostatic Neoplasms

NCT05151341 2025-07-24

URODX-FGFR3

Institut de Cancérologie de Lorraine

Phase NA Completed
190 enrolled
Genitourinary

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT04883827 2024-10-22

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

Vanderbilt-Ingram Cancer Center

Completed
180 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01598116 2021-12-14

A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas

Ohio State University

Completed
68 enrolled

Hemangioma

NCT03047616 2021-04-19

A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer

Abramson Cancer Center at Penn Medicine

Completed
88 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡